SEC Form 4 Reporting Owner · CIK 0001543031
Daphne Quimi
Director at Century Therapeutics Inc · Director at Amylyx Pharmaceuticals Inc · CFO at Amicus Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
26
Companies
3
Filing Activity
2026-06-12
first filed 2021-01-05
Trading record
Open-market buys
+$17.1K
2 filings
Open-market sales
−$311K
4 filings
Sales under a 10b5-1 plan
100%
4 of 4 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| IPSCCentury Therapeutics Insider trading | Director | 6 | 5,000 | — | +5,000 | 5,000 2024-09-16 |
| AMLXAmylyx Pharmaceuticals Insider trading | Director | 7 | 5,000 | — | +5,000 | 5,000 2024-05-16 |
| FOLDAmicus Therapeutics Insider trading | CFO | 13 | — | 26,514 | −26,514 | 398,532 2023-01-19 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.